ReviewJournal of the American Heart Association2016
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal Disease.
Review in Journal of the American Heart Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy and safety of angiotensin receptor-neprilysin inhibition in heart failure patients with end-stage kidney disease on maintenance dialysis: A systematic review and meta-analysis.European journal of heart failure · 2025Pooled it
- Delisting From the Kidney Transplant Waiting List: Impact on Patient Survival.Clinical transplantation · 2026Article
- Sacubitril/Valsartan in Patients with HFrEF Undergoing Maintenance Hemodialysis, Evidence of Cardiac Reverse Remodeling During 12-Month Follow-Up: Case Series.Reports (MDPI) · 2026Article
- Risk stratification and determinants of cardiac recovery in hemodialysis patients with reduced ejection fraction.Heart and vessels · 2026Article
- The Burden of Heart Failure in End-Stage Renal Disease: Insights from a Retrospective Cohort of Hemodialysis Patients.Journal of clinical medicine · 2025Article
- Efficacy and safety of sacubitril/valsartan in end-stage renal disease patients with heart failure: a review.Annals of medicine · 2025Review
- Assessment and management of emergencies during haemodialysis.Journal of nephrology · 2025Review
- Establishment of a nomogram that predicts the risk of heart failure in hemodialysis patients.American heart journal plus : cardiology research and practice · 2025Article
- Burden of heart failure attributable to chronic kidney disease in older adults (1990-2021): an analysis from the global burden of disease study.Frontiers in public health · 2025Article
- Case Report: Staged surgical management in ESRD: off-pump CABG followed by renal transplantation to enhance graft survival.Frontiers in cardiovascular medicine · 2025Article
- Nationwide trends and outcomes of percutaneous coronary intervention for stable ischemic heart disease in end-stage kidney disease: a longitudinal study.Annals of translational medicine · 2024Article
- The Association Between Serum TrimethylamineToxins · 2024Article
- Review
- The Burden of Cardiovascular Disease and Geriatric Syndromes in Older Patients Undergoing Chronic Hemodialysis.International journal of environmental research and public health · 2024Observational
- Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path.Reviews in cardiovascular medicine · 2024Review
- Systematic Review of Cardiovascular Benefits and Safety of Sacubitril-Valsartan in End-Stage Kidney Disease.Kidney international reports · 2024Article
- Giant Pancreatic Pseudocyst after Coronary Artery Bypass Graft in a Hemodialysis Patient: A Case Report.Clinics and practice · 2023Article
- Left ventricular strain echocardiography in advanced uremic cardiomyopathy compared to dilated cardiomyopathy.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023Article
- HEART and TIMI Scores Predict Severe Coronary Atherosclerosis in Patients With End-Stage Renal Disease.Cureus · 2023Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.